Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Molecular Cancer | journal | 6.896 Q1 | 196 | 162 | 477 | 12537 | 15669 | 446 | 35.77 | 77.39 | 41.54 | |
2 | Signal Transduction and Targeted Therapy | journal | 5.157 Q1 | 117 | 425 | 384 | 31800 | 7038 | 249 | 17.80 | 74.82 | 41.75 | |
3 | Journal of Hematology and Oncology | journal | 4.241 Q1 | 144 | 199 | 433 | 15362 | 8406 | 425 | 19.97 | 77.20 | 41.33 | |
4 | Journal for ImmunoTherapy of Cancer | journal | 3.450 Q1 | 117 | 551 | 994 | 23687 | 12239 | 988 | 10.91 | 42.99 | 42.42 | |
5 | PLoS Genetics | journal | 2.700 Q1 | 271 | 583 | 1676 | 40366 | 9855 | 1636 | 5.46 | 69.24 | 39.60 | |
6 | Oncogene | journal | 2.360 Q1 | 370 | 517 | 1451 | 26916 | 12964 | 1441 | 8.00 | 52.06 | 40.98 | |
7 | Cancer Communications | journal | 2.357 Q1 | 79 | 105 | 229 | 6574 | 2159 | 180 | 9.45 | 62.61 | 39.61 | |
8 | Journal of Experimental and Clinical Cancer Research | journal | 2.350 Q1 | 120 | 361 | 978 | 23361 | 11402 | 977 | 11.40 | 64.71 | 42.77 | |
9 | Breast Cancer Research | journal | 2.225 Q1 | 175 | 111 | 434 | 5041 | 3312 | 428 | 7.90 | 45.41 | 51.12 | |
10 | Cell Death and Disease | journal | 2.099 Q1 | 164 | 1101 | 3054 | 54830 | 28044 | 2993 | 8.83 | 49.80 | 42.63 | |
11 | Oncologist | journal | 1.813 Q1 | 189 | 460 | 1103 | 13809 | 6228 | 942 | 5.34 | 30.02 | 43.72 | |
12 | JNCI Cancer Spectrum | journal | 1.773 Q1 | 33 | 165 | 226 | 6417 | 972 | 199 | 4.35 | 38.89 | 49.42 | |
13 | Molecular Oncology | journal | 1.773 Q1 | 113 | 224 | 515 | 13171 | 3834 | 505 | 7.32 | 58.80 | 45.17 | |
14 | Oncogenesis | journal | 1.763 Q1 | 67 | 79 | 260 | 4217 | 1911 | 259 | 6.26 | 53.38 | 40.56 | |
15 | Cancer Science | journal | 1.587 Q1 | 166 | 449 | 1152 | 18678 | 7692 | 1146 | 6.41 | 41.60 | 26.53 | |
16 | Molecular Therapy - Oncolytics | journal | 1.530 Q1 | 42 | 181 | 268 | 10874 | 1713 | 268 | 6.14 | 60.08 | 40.29 | |
17 | ESMO Open | journal | 1.524 Q1 | 60 | 265 | 431 | 10001 | 2104 | 351 | 5.10 | 37.74 | 43.26 | |
18 | Cell Stress | journal | 1.517 Q1 | 27 | 22 | 123 | 1172 | 662 | 123 | 6.83 | 53.27 | 44.44 | |
19 | Neoplasia | journal | 1.424 Q1 | 144 | 114 | 279 | 6238 | 1722 | 277 | 6.07 | 54.72 | 41.99 | |
20 | Cell Death Discovery | journal | 1.399 Q2 | 58 | 368 | 350 | 17084 | 2117 | 333 | 6.67 | 46.42 | 41.47 | |
21 | Cancer Research and Treatment | journal | 1.359 Q2 | 58 | 126 | 414 | 3587 | 2130 | 413 | 5.10 | 28.47 | 37.95 | |
22 | Cancers | journal | 1.349 Q2 | 133 | 6342 | 6394 | 515698 | 42531 | 6261 | 6.47 | 81.31 | 44.90 | |
23 | Cellular oncology (Dordrecht) | journal | 1.326 Q2 | 58 | 89 | 194 | 6059 | 1305 | 189 | 6.84 | 68.08 | 45.78 | |
24 | Journal of global oncology | journal | 1.313 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
25 | JCO Global Oncology | journal | 1.302 Q2 | 39 | 193 | 616 | 6350 | 2076 | 547 | 3.77 | 32.90 | 42.15 | |
26 | Experimental Hematology and Oncology | journal | 1.301 Q2 | 42 | 58 | 101 | 3483 | 670 | 100 | 7.16 | 60.05 | 39.63 | |
27 | Epigenetics | journal | 1.296 Q2 | 111 | 79 | 299 | 4644 | 1597 | 299 | 5.10 | 58.78 | 47.15 | |
28 | Frontiers in Oncology | journal | 1.291 Q2 | 136 | 5851 | 4942 | 315606 | 29148 | 4841 | 5.47 | 53.94 | 42.09 | |
29 | Cancer Biology and Medicine | journal | 1.180 Q2 | 62 | 89 | 192 | 5150 | 1070 | 192 | 5.44 | 57.87 | 44.43 | |
30 | Breast | journal | 1.162 Q2 | 98 | 167 | 497 | 6088 | 2088 | 459 | 3.86 | 36.46 | 50.00 | |
31 | Tumour Virus Research | journal | 1.146 Q2 | 34 | 14 | 116 | 1387 | 534 | 109 | 4.62 | 99.07 | 45.68 | |
32 | Cancer Medicine | journal | 1.144 Q2 | 84 | 802 | 2176 | 30919 | 10517 | 2171 | 4.64 | 38.55 | 39.82 | |
33 | BMC Cancer | journal | 1.134 Q2 | 160 | 1320 | 3727 | 51492 | 18083 | 3726 | 4.52 | 39.01 | 39.02 | |
34 | Cancer Cell International | journal | 1.099 Q2 | 80 | 668 | 1113 | 36277 | 6711 | 1113 | 6.11 | 54.31 | 41.46 | |
35 | Translational Oncology | journal | 1.060 Q2 | 72 | 353 | 510 | 18268 | 2428 | 508 | 4.79 | 51.75 | 39.50 | |
36 | Cancer Biology and Therapy | journal | 0.888 Q2 | 130 | 62 | 442 | 3198 | 1951 | 437 | 4.33 | 51.58 | 34.35 | |
37 | Cancer Chemotherapy and Pharmacology | journal | 0.848 Q3 | 122 | 174 | 680 | 6355 | 2399 | 669 | 3.31 | 36.52 | 34.82 | |
38 | Infectious Agents and Cancer | journal | 0.837 Q3 | 47 | 69 | 160 | 3477 | 544 | 159 | 3.22 | 50.39 | 46.92 | |
39 | Journal of Breast Cancer | journal | 0.808 Q3 | 48 | 50 | 179 | 1256 | 538 | 175 | 2.74 | 25.12 | 41.12 | |
40 | Oncology Reviews | journal | 0.737 Q3 | 31 | 12 | 70 | 793 | 295 | 69 | 3.94 | 66.08 | 51.92 | |
41 | Journal of Gastric Cancer | journal | 0.716 Q3 | 37 | 38 | 120 | 1199 | 371 | 120 | 3.06 | 31.55 | 29.78 | |
42 | FASEB BioAdvances | journal | 0.713 Q3 | 18 | 91 | 118 | 4595 | 335 | 113 | 2.84 | 50.49 | 40.71 | |
43 | International Journal of Hyperthermia | journal | 0.709 Q3 | 98 | 197 | 601 | 7870 | 2231 | 574 | 3.58 | 39.95 | 36.22 | |
44 | Analytical Cellular Pathology | journal | 0.691 Q3 | 35 | 62 | 139 | 2894 | 552 | 136 | 4.12 | 46.68 | 46.63 | |
45 | ecancermedicalscience | journal | 0.665 Q3 | 47 | 183 | 392 | 6364 | 1182 | 389 | 3.12 | 34.78 | 45.14 | |
46 | JMIR Cancer | journal | 0.661 Q3 | 24 | 59 | 78 | 2683 | 249 | 78 | 3.37 | 45.47 | 52.25 | |
47 | Tumor Biology | journal | 0.643 Q3 | 101 | 27 | 142 | 1173 | 451 | 140 | 2.53 | 43.44 | 48.82 | |
48 | Pathology and Oncology Research | journal | 0.628 Q3 | 61 | 158 | 657 | 6445 | 1799 | 596 | 2.61 | 40.79 | 43.38 | |
49 | Technology in Cancer Research and Treatment | journal | 0.561 Q3 | 72 | 283 | 619 | 10593 | 1797 | 610 | 2.56 | 37.43 | 38.53 | |
50 | Breast Cancer: Basic and Clinical Research | journal | 0.554 Q3 | 35 | 25 | 79 | 1180 | 195 | 78 | 2.32 | 47.20 | 50.35 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®